← Back to Search

Low Mindfulness for Memory Loss

N/A
Waitlist Available
Research Sponsored by Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 20 minutes
Awards & highlights

Study Summary

This trial seeks to find out if noticing instances of forgetting leads to a decline in memory performance.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~20 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 20 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Test of Adult Cognition by Telephone with Stop-and-Go Switch Task (BTACT; (Tun & Lachman, 2006)
Everyday Memory Questionnaire-Revised (EMQ-R; Royle & Lincoln, 2008)
Memory Controllability Inventory (MCI; Lachman, Bandura, Weaver, & Elliott, 1995)
+1 more
Secondary outcome measures
Image of Aging Scale (Levy, Kasl, & Gill, 2004).
Langer Mindfulness Scale (LMS-14; Pirson, Langer, Bodner, & Zilcha, 2012)
Positive and Negative Affect Schedule (PANAS; Watson, Clark, & Tellegen, 1988)
+1 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Low MindfulnessExperimental Treatment1 Intervention
All participants in this condition will complete all measures online and over the phone at two points in time, including one narrative response at T1. They will also be instructed to respond to diary-type text messaging questions (some related to memory performance) twice daily for six days.
Group II: High MindfulnessExperimental Treatment1 Intervention
All participants in this condition will complete all measures online and over the phone at two points in time, including one narrative response at T1. They will also be instructed to complete a mindfulness intervention at home and respond to diary-type text messaging questions (all including questions about memory performance) twice daily for six days.
Group III: Active controlActive Control1 Intervention
All participants in this condition will complete all measures online and over the phone at two points in time, including one narrative response at T1. They will also be instructed to respond to diary-type text messaging questions (none about memory performance) twice daily for six days.

Find a Location

Who is running the clinical trial?

Harvard UniversityLead Sponsor
229 Previous Clinical Trials
474,295 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research endeavor accommodate participants who are of legal age?

"The minimum age for enrolment in this medical study is 65, whereas the maximum age of participants must not exceed 80 years old."

Answered by AI

What are the key goals of this clinical experiment?

"The primary outcome of this trial, which will be monitored over approximately 3 minutes is the Everyday Memory Questionnaire-Revised (EMQ-R; Royle & Lincoln, 2008). Secondary objectives include Subjective Age Measure (Barak & Schiffman, 1981) - an evaluation of cognitive, psychological, biological and social domains to ascertain how old participants feel they are compared to their actual age - Image of Aging Scale (Levy, Kasl, & Gill, 2004), a comparison between positive and negative stereotypes about aging across nine dimensions such as activity levels or physical health. Finally we have Langer Mindfulness Scale (LMS-14"

Answered by AI

Who is eligible to participate in this research project?

"This medical trial has a target enrollment of 210 seniors aged 65-80, who are experiencing memory difficulties and own smartphones. Furthermore, applicants must indicate that they have worries about their cognitive performance when asked to do so."

Answered by AI

Are there still opportunities for participants to join this clinical trial?

"The information hosted on clinicaltrials.gov demonstrates that this medical trial is not presently enrolling candidates. It was first posted on August 30th 2018 and its most recent update occurred October 25th 2021. Nonetheless, there are alternate trials currently admitting participants."

Answered by AI
~32 spots leftby Apr 2025